Company news
Canaquest Medical Corporation (OTC:CANQF) news
Canaquest Medical Corporation news releases on 6ix. Latest, Jun 11, 2024: CanaQuest Announces Key Appointments to Team to Drive CQ-001 through Clinical Trials
Press releases & updates
CanaQuest Announces Key Appointments to Team to Drive CQ-001 through Clinical Trials
June 10, 2024
NHL Alumni Association partners with CanaQuest and NEEKA Health to Conduct Studies for Anxiety and Quality of Life in former NHL Players
October 30, 2023
CANAQUEST Announces Award of European Cannabinoid Patent
September 18, 2023
CanaQuest Awarded Best Global Medical Cannabinoid Development Company 2023 by UK-based Global Health & Pharma for their 8th Annual Healthcare and Pharmaceutical Program
July 25, 2023
CanaQuest and Neeka Health Sign Agreement to Conduct Clinical Studies with Mentanine(R)
April 24, 2023
CanaQuest Achieves Statistically Significant Reduction of Seizures for Epilepsy Compared to Standard CBD
December 7, 2022
Canaquest Launches Mentanine (R) (Cannabidiol + IP Formula) in the US via WWW.CANAQUESTSTORE.COM, Supported by Western University Pre-Clinical Trials Targeting Anxiety, Depression and PTSD
September 7, 2022
CanaQuest Files International Mentanine(R) Patent, a Scientific CBD Formulation for Mental Health
April 28, 2021
CanaQuest Medical Corp Appoints Investor Relations and PR Veteran Rob Rinderman as its New Director of Communications
April 6, 2021
CanaQuest Medical Corp Honored With International CBD Life Science R & D Excellence Award 2020 by Global Health & Pharma
March 28, 2021
Fundamental Research Corp Initiates Coverage on CanaQuest (CANQF) with Buy Rating and US$0.78 Fair Value Estimate
March 22, 2021
CANAQUEST SIGNS MEDICINAL CANNABIS EDUCATION PARTNERSHIP WITH THE CANADIAN CANNABIS DISPUTE RESOLUTION CENTRE
March 11, 2021
CANAQUEST SIGNS MENTANINE® AND MENTABINOL® PRODUCTION AND DISTRIBUTION AGREEMENT WITH PURCANN PHARMA AND SILICYCLE INC.
February 2, 2021
CANAQUEST PRESIDENT INTERVIEWED BY THE WALL STREET ANALYZER
January 19, 2021
CANAQUEST ANNOUNCES MENTABINOL® A SCIENTIFIC DISCOVERY, AS PUBLISHED IN THE JOURNAL OF NEUROSCIENCE
December 3, 2020
CANAQUEST MEDICAL CORP SECURES APPROVAL FOR LISTING ON THE OCMX™, AN ONLINE INVESTOR AND FINANCIAL CONNECTION PORTAL
September 17, 2020
OCMX Listing
September 14, 2020
UPDATE: CANAQUEST MEDICAL CORP FILES PROVISIONAL PATENT FOR MENTANINE® - OMEGA-3 & PURE CANNABIDIOL (“CBD”) FORMULATION BOOSTING MENTAL HEALTH EFFICACY WHILE MINIMIZING CBD DOSAGE
July 14, 2020
CANAQUEST MEDICAL CORP FILES PROVISIONAL PATENT FOR MENTANINE® - OMEGA-3 & PURE CANNABIDIOL (“CBD”) FORMULATION BOOSTING MENTAL HEALTH EFFICACY WHILE MINIMIZING CBD DOSAGE
July 14, 2020
Canaquest Medical Corp Awaits Health Canada Approval for Sales and Export of Mentabinol®
February 6, 2020
CanQuest interview with Stock Day Podcast - NOv 25, 2019
November 24, 2019
CANAQUEST MEDICAL CORP is the Winner of the Go Global Awards "Business of the Year – Category of Life Science” presented by the International Trade Council
October 29, 2019
CanaQuest has developed a safer THC medical cannabis formulation (Metabinol™) from research and pre-clinical trials at Western University, London, Ontario, Canada
October 10, 2019
CANAQUEST MEDICAL CORP announces filing of INTERNATIONAL CANNABIS PATENT
September 17, 2019
CANAQUEST MEDICAL CORP announces filing of INTERNATIONAL CANNABIS PATENT
September 17, 2019
CANAQUEST MEDICAL CORP announces Award of a Cannabis Purchase/Sales Licence as permitted under the Health Canada Cannabis Act, through its wholly owned subsidiary, ADC BioMedical Corp.
September 10, 2019
CANAQUEST MEDICAL CORP has been selected as a Global Awards Finalist by the International Trade Council
August 14, 2019
CanaQuest Joins the Stock Day Podcast to Discuss Their Rapid Growth Plan
July 21, 2019
CanaQuest Medical Corp announces filing of Cannabis/Botanical Provisional Patents
February 5, 2019
CanaQuest Medical Corp (formerly Algae Dynamics) and Jamaican Medical Cannabis Corporation Announce Preliminary Agreement on Global Production, Distribution
January 30, 2019
Algae Dynamics Corp Changing Name to CanaQuest Medical Corporation
January 28, 2019
Algae Dynamics Corp Closes Second Tranche of CDN$947,000 Unit Offering
October 18, 2018
Algae Dynamics Corp Secures CDN$520,000 Funding from Accredited Investors
August 2, 2018
Algae Dynamics Corp Secures Bulk Cannabis Supply Agreement for Collaboration Partners
August 2, 2018
Algae Dynamics Corp provides Corporate Update
March 5, 2018
ALGAE DYNAMICS CORP ANNOUNCES C$400,000 RESEARCH GRANT FROM MITACS TO SUPPORT CANNABIS RESEARCH WITH UNIVERSITY OF WESTERN ONTARIO
November 16, 2017
ALGAE DYNAMICS CORP SECURES US $250,000 INVESTMENT FROM TEEWINOT LIFE SCIENCES CORPORATION
November 15, 2017
Algae Dynamics Corp Enters Into a Letter of Intent With Bonify to Produce Unique Cannabis Oil Products; Accelerates Go-to-Market Strategy
August 16, 2017
NetworkNewsWire Releases Exclusive Audio Interview with Algae Dynamics Corp. (ADYNF)
July 18, 2017
Algae Dynamics Corp. (ADYNF) Engages NetworkNewsWire for Corporate Communications Solutions
June 28, 2017
Algae Dynamics Corp Announces Engagement of Atlanta-Based Broker Dealer Carter, Terry & Company
May 11, 2017
Algae Dynamics Corp Announces Memorandum Of Understanding With Bonify for Supply of Cannabis, Oil Extraction and Sales
May 9, 2017
Algae Dynamics Corp Announces Joint Venture With ARA - Avanti Rx Analytics Inc. to Formulate, Manufacture and Sell Products Utilizing Algae, Hemp & Cannabis Oils
April 19, 2017
Algae Dynamics Corp Retains The Eversull Group as its Investor Relations and Public Relations Firm
April 18, 2017
Algae Dynamics Corp Revised Business Strategy to Include Product Development Using Other Botanicals Such as Cannabis and Hemp
March 30, 2017
Algae Dynamics Corp Announces Memorandum of Understanding With Company Licenced by Health Canada to Test, Extract, Purify, Import/Export and Sell Cannabis Oil
March 16, 2017
Algae Dynamics Corp Announces Research Agreement With University of Western Ontario to Investigate the Use of Cannabis Derivatives for the Development of Novel Pharmacotherapies for Mental Health
March 13, 2017
ALGAE DYNAMICS CORP Announces Research Agreement With University of Waterloo to Investigate Use of Cannabis Oil in the Context of Cancer
February 24, 2017
ALGAE DYNAMICS CORP Announces New Oil Extraction Initiative Into the Canadian Cannabis Industry
December 21, 2016
OTC Markets Group Welcomes Newly Verified OTCQB Companies – January 6
January 6, 2016